The effects of FR167653 in extended liver resection with ischemia in dogs

Interleukin‐1 (IL‐1) and tumor necrosis factor (TNF) are cytokines commonly associated with inflammatory conditions such as hepatic injury after ischemia‐reperfusion. FR167653 has been characterized as a potent suppressant of IL‐1β and TNF‐α production. In this study, we evaluated the effect of FR167653 in an extended liver resection with ischemia in a dog model. The right portal pedicle was clamped for 60 minutes, while the left portal branch was patent to avoid portal congestion. Following reperfusion, 75% of the liver (including the right central, quadrate, left central, left lateral, and papillary lobes) were resected. Animals were divided into two groups: a control group (n = 10), and a FR‐treated group (n = 6) in which FR167653 was administered via the portal vein. Hepatic venous blood was collected to measure alanine transaminase (ALT), aspartate transaminase (AST), lactate dehydrogenase (LDH), purine nucleoside phosphorylase (PNP), and hyaluronic acid (HA) levels, and IL‐1β expression was also measured by reverse‐transcriptase polymerase chain reaction (RT‐PCR). ALT, AST, LDH, PNP, and HA levels after reperfusion were significantly lower (P < .05) in the FR‐treated group than in the control group, and the FR‐treated group showed inhibited IL‐1β expression. Liver tissue blood flow, measured by a laser Doppler flow meter, was kept higher in the FR‐treated group than in the control group. Histologically, tissue damage was mild in the FR‐treated group. The 2‐day survival rate was statistically better (P < .05) in the FR‐treated group than in the control group. We conclude that FR167653 provides a protective effect for liver parenchyma and sinusoidal endothelial cells in extended liver resection with ischemia.

[1]  Y. Otani,et al.  The effect of FR167653 on pulmonary ischemia-reperfusion injury in rats. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  H. Yamazaki,et al.  FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock. , 1997, European journal of pharmacology.

[3]  T. Starzl,et al.  Attenuation of ischemic liver injury by augmentation of endogenous adenosine. , 1997, Transplantation.

[4]  H. Yamazaki,et al.  Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. , 1996, European journal of pharmacology.

[5]  Y. Morishita,et al.  Effects of neutrophil elastase inhibitor on reperfusion injury in the canine liver. , 1996, Transplantation proceedings.

[6]  M. Shimada,et al.  Significance of hyaluronic acid for evaluation of hepatic endothelial cell damage after cold preservation/reperfusion. , 1995, The Journal of surgical research.

[7]  A. Chong,et al.  Inactivation of kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts , 1995, Hepatology.

[8]  L. Bermudez,et al.  Effects of pentoxifylline pretreatment on Kupffer cells in rat liver transplantation , 1995, Hepatology.

[9]  T. Ishii,et al.  The Pringle maneuver induces only partial ischemia of the liver. , 1995, Hepato-gastroenterology.

[10]  C. Brass,et al.  Evaluation of purine nucleoside phosphorylase release as a measure of hepatic endothelial cell injury , 1995, Hepatology.

[11]  K. Fujiwara,et al.  Oxidative stress in hepatocytes and stimulatory state of Kupffer cells after reperfusion differ between warm and cold ischemia in rats. , 2008, Liver.

[12]  D. Remick,et al.  Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necrosis factor interactions. , 1994, The American journal of physiology.

[13]  J. Lemasters,et al.  Evidence that activation of Kupffer cells increases oxygen uptake after cold storage. , 1994, Transplantation.

[14]  K. Shirabe,et al.  BENEFICIAL EFFECT OF THROMBOXANE A2 SYNTHETASE INHIBITOR ON COLD‐STORED RAT LIVER , 1994, Transplantation.

[15]  R. Bast,et al.  Regulation of tumour necrosis factor-α processing by a metalloproteinase inhibitor , 1994, Nature.

[16]  L. Toledo-Pereyra,et al.  Interleukin 1 and tumor necrosis factor production as the initial stimulants of liver ischemia and reperfusion injury. , 1994, The Journal of surgical research.

[17]  L. Toledo-Pereyra,et al.  NEUTROPHIL INFILTRATION AS AN IMPORTANT FACTOR IN LIVER ISCHEMIA AND REPERFUSION INJURY , 1993, Transplantation.

[18]  K. Fujiwara,et al.  Sinusoidal endothelial cell damage by activated macrophages in rat liver necrosis. , 1993, Gastroenterology.

[19]  J. Spitzer,et al.  Hyaluronic acid uptake by the isolated, perfused rat liver: An index of hepatic sinusoidal endothelial cell function , 1993, Hepatology.

[20]  K. Tracey,et al.  Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.

[21]  H. Jaeschke,et al.  Superoxide generation by neutrophils and Kupffer cells during in vivo reperfusion after hepatic ischemia in rats , 1992, Journal of leukocyte biology.

[22]  M. Yokoyama,et al.  [Rapid assay of hyaluronic acid in serum]. , 1991, Rinsho byori. The Japanese journal of clinical pathology.

[23]  H. Jaeschke,et al.  Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. , 1991, The American journal of physiology.

[24]  J. Bauer,et al.  Effects of cytokines on the liver , 1991, Hepatology.

[25]  T. Starzl,et al.  Levels of purine nucleoside phosphorylase (PNP) as a viability marker of nonparenchymal cells in cold preserved livers. , 1991, Transplantation proceedings.

[26]  J. Lemasters,et al.  Kupffer cell activation and endothelial cell damage after storage of rat livers: Effects of reperfusion , 1991, Hepatology.

[27]  C. Smith,et al.  Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  F. Ma,et al.  Hyaluronic acid in the assessment of liver graft function. , 1990 .

[29]  R. Strieter,et al.  Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. , 1990, The Journal of clinical investigation.

[30]  R. Strieter,et al.  The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. , 1990, Transplantation.

[31]  T. Starzl,et al.  Purine nucleoside phosphorylase: A new marker for free oxygen radical injury to the endothelial cell , 1990, Hepatology.

[32]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[33]  J. Larrick,et al.  Recombinant tumor necrosis factor causes activation of human granulocytes. , 1987, Blood.

[34]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[35]  L. Toledo-Pereyra,et al.  INFLUENCE OF OXYGEN‐DERIVED FREE RADICAL SCAVENGERS ON ISCHEMIC LIVERS , 1985, Transplantation.

[36]  B. Aggarwal,et al.  Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. , 1985, Journal of immunology.

[37]  S. Mitsuhashi,et al.  Purine Metabolic Enzymes in Lymphocytes: I. Adenosine Deaminase and Purine Nucleoside Phosphorylase Activities in Mouse Lymphocyte Subpopulations , 1982, Microbiology and immunology.

[38]  O. Wangensteen,et al.  Tolerance of dogs to occlusion of entire afferent vascular inflow to the liver. , 1950, Surgical forum.